LEVOSULPIRIDE IN PREMATURE EJACULATION

Authors

  • Syed Javid Hussain
  • Atif Hameed
  • Hassan Shahzad Nazar
  • Ania Javid
  • Yousaf Shah
  • Waqas Hameed
  • Muhammad Shah Miran

Abstract

Background: Premature ejaculation is one of the most common sexual disorders. A large number of
treatment options have been used so far for the treatment of this dysfunction and still a large number of
experts are doing research in this field. Here we have tried to research on the beneficial effects of
levosulpiride in the treatment of PE. Methods: Eighty-eight patients form different areas of Hazara
division suffering from PE were chosen. Sixty-four patients were given levosulpiride and the remaining
24 patients were given Placebo. Results: Out of 64 patients who have been given levosulpiride, 30
patients showed very good improvement, 14 patients showed some improvement, 14 patients showed
little and 06 patients showed no improvement. Conclusion: levosulpiride have very good beneficial
effects in the treatment of PE.
Keywords: levosulpiride, premature ejaculation

References

Master VA, Johnson PJ. Ejaculatory physiology and dysfunction.

Urol. Clin. North Am. 2001;28(2):363-75.

Kinsey A, Pomeroy W, Martin C, & Gebhard P. Sexual

Behaviour in the Human Male, Philadelphia: Saunders (1953);

ISBN978-0253334114.

Ejaculation delay: what's normal? Bandolier Books.

http://www.medicine.ox.ac.uk/bandolier/band137/b137-4.html.

Retrieved 2007-10-21.

Waldinger MD, Quinn P, Dilleen M, Mundayat R, Schweitzer

DH, Boolell M. A multinational population survey of

intravaginal ejaculation latency time. J Sexual Med

:2(4):492-7.

Waldinger MD, Zwinderman AH, Olivier B, Schweitzer DH.

Proposal for a definition of lifelong premature ejaculation based

on epidemiological stopwatch data. J Sexual Med

;2(4):498-507.

Robert L. Marrone, Body of knowledge: an introduction to

body/mind psychology. Place of Publication: SUNY Press; 1990,

p. 104.

Böhlen D, Hugonnet CL, Mills RD, Weise ES, Schmid HP. Five

meters of H2O: the pressure at the urinary bladder neck during

human ejaculation. Prostate 2000 44(4):339-41.

Master VA, Johnson PJ. Ejaculatory physiology and dysfunction.

Urol Clin North Am 2001;28(2):363-75.

deGroat WC, Booth AM. Physiology of male sexual function.

Ann Intern Med 1980;92 (2 Pt 2): 329-31.

Truitt WA, Coolen LM (2002). Identification of a potential

ejaculation generator in the spinal cord. Science

;297(5586):1566-9.

Coolen LM, Olivier B, Peters HJ, Veening JG. Demonstration of

ejaculation-induced neural activity in the male rat brain using 5-

HT1A agonist 8-OH-DPAT. Physiol Behav 1997;62(4):881-91.

Premature Ejaculation. Premature Ejaculation and Male

Orgasmic Disorder. Armenian Medical Network 2006.

http://www.health.am/sex/premature-ejaculation/ Retrieved

-09-19.

Kendirci M, Salem E, Hellstrom WJ. Dapoxetine, a novel

selective serotonin transport inhibitor for the treatment of

premature ejaculation. Ther Clin Risk Manag 2007;3(2):277-89.

PPD Reports First Quarter 2009 Financial Results. Available at:

http://investor.ppdi.com/releasedetail.cfm?releaseid=492822

J Ayub Med Coll Abbottabad 2010;22(4)

http://www.ayubmed.edu.pk/JAMC/PAST/22-4/Javid.pdf

Janssen-Cilag EMEA announces receipt of first regulatory

approvals for Priligy for PE in Finland and Sweden, February 11,

Available from: http://www.tradingmarkets.com/.site/news/

Stock%20News/2170588/

Sidi AA, Cameron JS, Dykstra DD, Reinberg Y, Lange PH.

Vasoactive intracavernous pharmacotherapy for the treatment of

erectile impotence in men with spinal cord injury. J Urol

;138(3):539-42.

Downloads

Published

2010-12-01

How to Cite

Hussain, S. J., Hameed, A., Nazar, H. S., Javid, A., Shah, Y., Hameed, W., & Miran, M. S. (2010). LEVOSULPIRIDE IN PREMATURE EJACULATION. Journal of Ayub Medical College Abbottabad, 22(4), 124–126. Retrieved from https://jamc.ayubmed.edu.pk/index.php/jamc/article/view/2729

Issue

Vol. 22 No. 4 (2010): JOURNAL OF AYUB MEDICAL COLLEGE, ABBOTTABAD

Section

ORIGINAL ARTICLE

License

Journal of Ayub Medical College, Abbottabad is an OPEN ACCESS JOURNAL which means that all content is FREELY available without charge to all users whether registered with the journal or not. The work published by J Ayub Med Coll Abbottabad is licensed and distributed under the creative commons License  CC BY ND Attribution-NoDerivs. Material printed in this journal is OPEN to access, and are FREE for use in academic and research work with proper citation. J Ayub Med Coll Abbottabad accepts only original material for publication with the understanding that except for abstracts, no part of the data has been published or will be submitted for publication elsewhere before appearing in J Ayub Med Coll Abbottabad. The Editorial Board of J Ayub Med Coll Abbottabad makes every effort to ensure the accuracy and authenticity of material printed in J Ayub Med Coll Abbottabad. However, conclusions and statements expressed are views of the authors and do not reflect the opinion/policy of J Ayub Med Coll Abbottabad or the Editorial Board.

USERS are allowed to read, download, copy, distribute, print, search, or link to the full texts of the articles, or use them for any other lawful purpose, without asking prior permission from the publisher or the author. This is in accordance with the BOAI definition of open access.

AUTHORS retain the rights of free downloading/unlimited e-print of full text and sharing/disseminating the article without any restriction, by any means including twitter, scholarly collaboration networks such as ResearchGate, Academia.eu, and social media sites such as Twitter, LinkedIn, Google Scholar and any other professional or academic networking site.